Galmed Pharmaceuticals (GLMD) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Galmed Pharmaceuticals Ltd. has announced a reverse stock split at a ratio of 1-for-12, effective after market close on August 29, 2024. Post-split, the company will have approximately 632,889 ordinary shares with a par value of NIS 1.80 each. The adjustment will also affect the exercise price and number of shares available through existing options.
For further insights into GLMD stock, check out TipRanks’ Stock Analysis page.